Edwards Lifesciences recently announced that it would acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement (“TMVR”) company. Edwards had the option to acquire Innovalve ...

Edwards Lifesciences said Monday it exercised an option to buy Innovalve Bio Medical, an Israel-based startup that is developing transcatheter mitral valve replacement technologies. Edwards expects to ...

Edwards Lifesciences, a medical technology company based in the US, has announced the complete acquisition of Innovalve Bio Medical, which specialises in transcatheter heart valve devices. The ...

Edwards Lifesciences recently exercised its option to acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement (TMVR) company. The company expects to pay about $300 million ...

(RTTNews) - Edwards Lifesciences (EW) said it has exercised its option to acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement company, following its initial investment ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve ...

Edwards Lifesciences Corp. (NYSE: EW) today announced its plans to acquire Innovalve Bio Medical, an early stage transcatheter mitral valve replacement (TMVR) company, for about $300 million in cash.